Lowey Dannenberg Notifies Immunitybio, Inc. (“Immunitybio” Or The“Company”) (NASDAQ: IBRX) Investors Of Securities Class Action Lawsuit And Encourages Investors With More Than $100,000 In Losses To Contact The Firm
On March 26, 2026, a complaint was filed against the Company and one of its current officer, alleging that throughout the Class Period, Defendants misrepresented and failed to disclose that: (1) Defendant Soon-Shion materially overstated Anktiva's capabilities; and (2) as a result, Defendants' statements about ImmunityBio's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
When investors learned the truth, ImmunityBio's common stock declined precipitously, injuring investors.
If you suffered a loss of more than $100,000 in ImmunityBio's common stock, and wish to participate, or learn more about your eligibility, please contact our attorneys Andrea Farah (... ) at (914)733-7256 or Vincent R. Cappucci Jr. (... ) at (914)733-7278.
Any investor who wishes to serve as Lead Plaintiff must act before May 26, 2026.
About Lowey Dannenberg
Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.
Contact:
Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7234
Email:...
SOURCE: Lowey Dannenberg P.C.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment